Don’t Miss the Opportunity | Lasa Supergenerics Ltd | Investing | Stocks and Shares |
Lasa Supergenerics Ltd, the newborn company after the corporate restructuring of Omkar Specialty Chemicals Ltd, is engaged in the development and production of drugs- veterinary, animal and human healthcare segments, active pharmaceutical ingredients – APIs, animal feed ingredients, and therapeutic reagents. Its facilities at Mahad and Chiplun both in Maharashtra Konkan region have an annual production capacity 4,300 tons of pharma products. The company, which produced 500 tons of pharmaceuticals in 2017-18, is going to achieve 1,000 tons output in 2018-19, 2,000 tons in 2019-20, and 100% capacity utilization in 2010-21.
Please Click the Below Link
Lasa Supergenerics, whose shares got listed on stock exchanges on September 21, 2017, has a 35% market share in the animal health-care segment. Up to 80% of its total income is coming from 7-8 products. It has developed seven processes for which it would get the patents soon. Its product portfolio comprised 10-USFDA-approved drugs. The company is exporting 25% of its APIs to 27 countries. Each of the products has 200 customers worldwide.
The company which earned Rs 3.11 crore net profit in the third quarter ended December 31, 2017, recorded Rs 18.81 crore in the first nine months ended December 31, 2017. Since it is a newly created company, there are no previous figures to compare.
The promoters are controlling 39.75% stake in the equity capital of Rs 22.86 crore. Lasa Supergenerics is proposing a rights issue to mobilise funds required for backward integration. The company shook hands with the Chinese CIDIC Group. Both companies signed a ‘business association’ agreement. This deal helps the company to enter South East Asian markets where margins are high.
The veterinary market is growing at a rate of up to 27% per annum. Though there is sufficient demand in this segment, how to meet it is the big challenge.
The beauty of this stock is its market price, which is hovering at around Rs 110 per share of Rs 10. It is a striking opportunity for investment.
BSE Code: 540702
Face Value: Rs 10.00
Market Price: Rs 92.80/- (As on 09 Mar 18 | 16:00)